Language: 中文  |  Eng
Home About Us Doctors List New Join Doctor Comment Contact Us
Doctor's Name District Category Gender Speciality
Full Name or SurnameHot Second Hot
Building Name Time Slot Date Fee Range Keyword Search
To
研究揭16%人接種科興半年後抗體未達5成 恐白捱兩針
 

研究揭16%人接種科興半年後抗體未達5成 恐白捱兩針

本港現時提供2種新冠疫苗接種選項,包括由內地研發的科興疫苗及由內地及德國研發的復必泰疫苗。政府專家顧問、中大呼吸系統科講座教授許樹昌及其研究團隊發現,接種2針科興1個月已有8.2%人抗體水平未達世衞標準,接種半年後,更只有16%接種者保護力合格,而接種復必泰疫苗產生的抗體水平亦較科興高。研究結果已於學術期刊刊登。

研究發現,接種2針科興針後1個月,僅91.8%人抗體保護力達至世衞標準的50%,而針後半年的測試中,更只有16.3%人達標;復必泰針後1個月的抗體保護力則全數達至世衞標準,針後半年仍有79.6%人抗體達合格水平。

團隊又分別於接種前和接種後1個月,分別抽取10毫升血液進行多項抗體測試。發現接種復必泰的人士針後1個月中和抗體水平為251.6,而接種科興者僅錄69.45,反映打復必泰的抗體水平較科興高2.6倍。

 

資料來源:東方日報 07-12-2021

選文來自:香港E大夫/醫大夫

 

 

E大夫醫生網是香港人最喜愛的醫療網站

E-Daifu.com

The above information is not medical advice, for reference only / from :

This Site Does Not Provide Medical Advice
The contents of the articles from E-daifu Site are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the E-daifu!This website and related information providers are not responsible for any errors in the information.

     
   Close

   Close

WhatsApp Number:5548-8918

Close

E-Daifu App